Inspire Investing LLC Sells 11,637 Shares of Maximus, Inc. $MMS

Inspire Investing LLC reduced its holdings in shares of Maximus, Inc. (NYSE:MMSFree Report) by 59.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,997 shares of the health services provider’s stock after selling 11,637 shares during the period. Inspire Investing LLC’s holdings in Maximus were worth $513,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of MMS. Norges Bank purchased a new stake in Maximus in the fourth quarter worth about $60,393,000. River Road Asset Management LLC lifted its holdings in shares of Maximus by 236.1% during the fourth quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider’s stock valued at $71,064,000 after purchasing an additional 578,326 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Maximus by 218.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 583,627 shares of the health services provider’s stock worth $50,379,000 after purchasing an additional 400,315 shares in the last quarter. Boston Partners boosted its position in shares of Maximus by 47.0% in the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock worth $88,236,000 after purchasing an additional 308,892 shares in the last quarter. Finally, The Manufacturers Life Insurance Company grew its stake in shares of Maximus by 493.0% in the 4th quarter. The Manufacturers Life Insurance Company now owns 342,266 shares of the health services provider’s stock worth $29,544,000 after buying an additional 284,548 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a report on Saturday, June 6th. Finally, Weiss Ratings cut Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Two analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold”.

Read Our Latest Analysis on MMS

Maximus Stock Performance

Shares of MMS stock opened at $55.80 on Friday. The company has a 50 day moving average price of $60.38 and a 200-day moving average price of $72.90. Maximus, Inc. has a 52 week low of $52.73 and a 52 week high of $100.00. The firm has a market capitalization of $2.93 billion, a PE ratio of 8.35 and a beta of 0.60. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87.

Maximus (NYSE:MMSGet Free Report) last issued its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.98 by $0.09. Maximus had a net margin of 7.02% and a return on equity of 25.10%. The company had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.32 billion. During the same quarter in the prior year, the firm earned $2.01 earnings per share. The firm’s revenue for the quarter was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. As a group, equities research analysts expect that Maximus, Inc. will post 8.43 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were paid a dividend of $0.33 per share. The ex-dividend date was Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a yield of 2.4%. Maximus’s payout ratio is currently 19.76%.

About Maximus

(Free Report)

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

See Also

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.